ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
4,1,Postoperative wound complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
6,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
6,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
7,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
8,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
9,1,Rubber sensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
10,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
11,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
12,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
12,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,3,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
13,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
14,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
15,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
16,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
17,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
17,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
17,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
17,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
18,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
18,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
18,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
19,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
19,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
20,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
21,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
21,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
24,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
24,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
25,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
25,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
27,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
28,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
29,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
30,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
31,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
32,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
33,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,Y
33,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
33,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
34,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
35,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
35,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
36,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
36,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
36,3,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
36,4,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
37,1,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
38,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
39,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
39,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
40,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
41,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
41,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
41,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
41,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
41,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
41,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
42,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
43,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
43,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
44,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
45,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
46,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
47,1,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
48,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
48,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
48,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
48,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
49,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
50,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
51,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
52,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
53,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
54,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
55,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
55,2,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
56,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
56,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
57,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
58,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
59,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
60,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
61,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
62,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
62,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
63,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
63,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
63,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
64,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
64,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
65,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
66,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
67,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
67,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
68,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
69,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
69,2,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
70,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
71,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
72,1,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
73,1,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
74,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
74,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
74,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
74,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
75,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
76,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
77,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
78,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
78,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
78,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
79,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
79,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
80,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
81,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
81,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
82,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
82,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
83,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
84,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
85,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
85,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
85,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
86,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
87,2,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
88,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
90,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
91,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
92,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
92,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
93,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
94,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
94,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
94,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
94,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
96,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
97,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
98,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
99,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
99,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
99,3,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
100,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
100,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
100,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
101,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
101,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
102,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
103,1,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
104,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
105,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
105,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
106,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
107,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
107,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
108,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
108,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
108,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
108,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
108,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
109,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
111,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
112,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
113,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
114,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
114,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
115,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
116,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
117,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
118,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
119,1,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
120,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
120,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
121,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
121,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
121,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
121,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
122,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
122,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
123,1,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
124,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
124,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
124,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
125,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
126,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
126,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
126,3,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
126,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
127,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
128,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
129,1,Thyroid function test abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
130,1,Erythema induratum,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
130,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
130,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
130,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
131,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
132,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
132,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
132,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
132,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
132,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
133,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
134,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
135,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
136,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
137,1,Aplasia cutis congenita,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
138,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
138,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
139,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
140,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
140,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
141,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
142,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
143,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
144,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
145,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
146,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
147,1,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
148,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
148,2,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,Y
149,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
150,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
150,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
151,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
152,1,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
152,2,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
153,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
153,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
154,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
155,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
156,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
156,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
157,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
157,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
158,1,Aplasia cutis congenita,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
159,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
160,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
161,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
162,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
162,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
163,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
163,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
164,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
164,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
164,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
164,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
165,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
166,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
166,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
167,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
167,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
168,1,Haemobilia,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,Y
169,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
169,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
170,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
171,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
171,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
172,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
172,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
173,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
174,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
175,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
176,1,Blood loss anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
176,2,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
176,3,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
177,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
177,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,1,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
179,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
179,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
180,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
181,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
181,2,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
182,1,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
183,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
183,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
184,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
185,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
186,1,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
187,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
188,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
188,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
189,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
190,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
190,2,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
191,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
191,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
191,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
192,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
192,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
192,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
193,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
193,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
194,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
194,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
195,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
195,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
195,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
195,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
196,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
196,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
197,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
198,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
199,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
200,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
201,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
202,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
202,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
203,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
203,2,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
204,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
204,2,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
205,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
205,2,Body height decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
205,3,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
205,4,Sternal fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
206,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
207,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
207,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
208,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
209,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
210,1,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
211,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
211,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
211,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
211,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
212,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
212,2,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
213,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
213,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
213,3,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
214,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
214,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
215,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
215,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
215,3,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
215,4,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
216,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
216,2,Pelvic haematoma obstetric,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
217,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
217,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
218,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
218,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
219,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
219,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
220,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
220,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
220,3,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
220,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
221,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
221,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
222,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
222,2,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
223,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
223,2,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
224,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
224,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
225,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
225,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
226,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
226,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
227,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
227,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
228,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
228,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
229,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
229,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
230,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
230,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
231,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
231,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
231,3,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
231,4,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
232,1,Anaemia folate deficiency,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
232,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
232,3,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
233,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
233,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
234,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
234,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
234,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
234,4,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
234,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
234,6,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
234,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
234,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
234,9,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
234,10,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
234,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
235,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
235,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
236,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
237,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
237,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
237,3,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
237,4,Stroke in evolution,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
238,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
238,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
239,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
240,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
240,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
241,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
241,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
242,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
242,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
243,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
243,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
243,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
243,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
243,5,Poor feeding infant,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
243,6,Transient tachypnoea of the newborn,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
244,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
244,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
245,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
245,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
246,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
246,2,Pyelocaliectasis,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
247,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
247,2,Pyelocaliectasis,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
248,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
248,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
249,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
249,2,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
250,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
250,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
250,3,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
251,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
251,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
251,3,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
251,4,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
252,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
252,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
253,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
253,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
254,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
254,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
255,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
255,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
255,3,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
256,1,Congenital cystic kidney disease,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
256,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
257,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
257,2,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
258,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
258,2,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
259,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
259,2,Pyelocaliectasis,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
260,1,Congenital skin dimples,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
260,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
260,3,Karyotype analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
260,4,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
261,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
261,2,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
262,1,Cryptorchism,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
262,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
262,3,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
263,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
263,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
264,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
264,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
265,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
265,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
266,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
266,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
267,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
267,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,1,Acute lung injury,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
268,2,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
268,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
268,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
269,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
269,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
269,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
270,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
271,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
271,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
271,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
271,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
271,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
271,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
271,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
272,1,Haemobilia,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
273,1,Acute lung injury,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
274,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
274,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
274,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
275,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
275,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
275,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
276,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
277,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
277,2,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
277,3,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
277,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
277,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
277,6,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
277,7,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
277,8,Muscle necrosis,Myopathies,Muscle disorders,Musc,N
277,9,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
277,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
277,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
277,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
278,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
279,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
280,1,Septic phlebitis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
281,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
281,2,Headache,Headaches NEC,Headaches,Nerv,N
281,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
281,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
282,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
282,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
282,3,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
282,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
283,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
284,1,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
285,1,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
285,2,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
285,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
286,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
286,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
286,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
286,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
286,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
286,6,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
286,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
286,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
286,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
286,10,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
286,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
287,1,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
288,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
288,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
289,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
290,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
290,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
291,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
291,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
291,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
291,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
291,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
291,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
291,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
292,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
293,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
293,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
293,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
293,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
293,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
293,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
293,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
293,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
294,1,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
295,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
295,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
296,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
296,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
296,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
296,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
296,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
297,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
298,1,Haemorrhagic cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
299,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
300,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
301,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
301,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
302,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
302,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
302,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
302,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
303,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
303,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
303,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
303,4,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
304,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
305,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
306,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
306,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
306,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
306,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
307,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
307,2,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
307,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
307,4,Neurological complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
307,5,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
307,6,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
308,1,Abdominal compartment syndrome,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,Y
308,2,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
308,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
309,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
309,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
309,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
309,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
309,5,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
309,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
310,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
310,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
311,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
312,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
312,2,Foetal heart rate abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
312,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
313,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
313,2,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
313,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
314,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
314,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
315,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
315,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
315,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
315,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
316,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
316,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
316,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
316,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
317,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
318,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
318,2,Arterial haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
318,3,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
318,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
319,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
320,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
320,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
321,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
321,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
321,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
321,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
321,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
322,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
323,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
323,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
323,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
324,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
324,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
324,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
325,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
325,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
326,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
326,2,Idiopathic urticaria,Urticarias,Angioedema and urticaria,Skin,N
326,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
327,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
328,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
328,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
328,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
329,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
329,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
330,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
330,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
330,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
330,4,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
331,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
332,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
332,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
332,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
332,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
333,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
334,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
334,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
334,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
334,4,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
334,5,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
334,6,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
334,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
334,8,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
334,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
335,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
336,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
337,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
338,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
338,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
338,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
338,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
338,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
339,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
339,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
340,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
341,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
341,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
342,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
342,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
342,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
342,4,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
342,5,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
342,6,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
342,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
342,8,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
343,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
343,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
343,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
344,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
345,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
346,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
346,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
347,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
348,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
348,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
348,3,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
349,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
350,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
350,2,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
350,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
351,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
352,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
353,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
353,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
354,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
354,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
355,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
355,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
356,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
357,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
358,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
358,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
359,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
360,1,Fractured sacrum,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
360,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
361,1,Injection site hypoaesthesia,Injection site reactions,Administration site reactions,Genrl,N
362,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
363,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
363,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
363,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
363,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
364,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
365,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
365,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
365,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
365,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
366,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
366,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
366,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
367,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
368,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
368,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
368,3,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
369,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
369,2,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
370,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
370,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
370,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
371,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
371,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
371,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
371,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
371,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
372,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
373,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
374,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
375,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
376,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
376,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
376,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
376,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
377,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
378,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
379,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
380,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
380,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
381,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
381,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
382,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
383,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
384,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
384,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
384,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
384,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
385,1,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
385,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
385,3,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
386,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
387,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
387,2,Headache,Headaches NEC,Headaches,Nerv,N
387,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
388,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
388,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
388,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
389,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
389,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
390,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
390,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
390,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
390,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
390,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
391,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
391,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
391,3,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
392,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
392,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
392,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
393,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
393,2,Cervicogenic headache,Headaches NEC,Headaches,Nerv,N
393,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
393,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
393,5,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
393,6,Faeces soft,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
393,7,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
393,8,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
393,9,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
393,10,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
393,11,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
394,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
395,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
396,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
397,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
398,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
398,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
399,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
399,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
399,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
399,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
399,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
399,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
400,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
401,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
401,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
402,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
402,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
402,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
402,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
403,1,Device related thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
403,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
404,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
404,2,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
405,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
405,2,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
406,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
407,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
408,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
408,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
408,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
409,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
409,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
409,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
410,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
411,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
412,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
412,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
412,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
413,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
413,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
413,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
413,4,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
414,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
415,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
415,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
415,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
416,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
416,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
416,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
417,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
418,1,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
418,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
418,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
419,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
420,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
421,1,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
422,1,Abdominal wall haemorrhage,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
422,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
422,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
422,4,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
422,5,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
422,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
423,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
423,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
423,3,Hepatic haemorrhage,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
423,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
423,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
423,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
424,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
424,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
424,3,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
424,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
424,5,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
425,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
426,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
426,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
427,1,Arterial haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
427,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
427,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
427,4,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
427,5,Peripartum cardiomyopathy,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
427,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
427,7,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
428,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
428,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
429,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
429,2,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
429,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
430,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
430,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
431,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
432,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
433,1,Device physical property issue,Device physical property and chemical issues,Device issues,Prod,N
433,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
434,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
434,2,Dose calculation error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
434,3,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
435,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
436,1,Basilar artery occlusion,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
436,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
436,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
436,4,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
436,5,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
436,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
437,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
438,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
438,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
439,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
440,1,Basilar artery occlusion,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
440,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
440,3,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
440,4,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
441,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
442,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
442,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
443,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
443,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
443,3,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
444,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
444,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
445,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
445,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
446,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
446,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
446,3,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
447,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
448,1,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
449,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
450,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
450,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
450,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
451,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
451,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
451,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
451,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
452,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
452,2,Encephalopathy neonatal,Encephalopathies NEC,Encephalopathies,Nerv,N
453,1,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
454,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
454,2,Headache,Headaches NEC,Headaches,Nerv,N
454,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
455,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
455,2,NIH stroke scale score increased,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
456,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
456,2,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
456,3,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
457,1,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
458,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
459,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
459,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
459,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
460,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
461,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
461,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
461,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
462,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
463,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
464,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
464,2,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
464,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
464,4,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
465,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
465,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
465,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
466,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
466,2,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
466,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
467,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
467,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
467,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
467,4,Wound haematoma,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
468,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
469,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
469,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
470,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
471,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
472,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
473,1,Congenital bladder anomaly,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
473,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
473,3,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
473,4,Genitalia external ambiguous,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
473,5,Neonatal respiratory depression,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
474,1,Headache,Headaches NEC,Headaches,Nerv,N
475,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
476,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
477,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
477,2,Wrong schedule,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
478,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
479,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
479,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
480,1,Choroidal haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
480,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
480,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
480,4,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
480,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
481,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
482,1,Choroidal haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
482,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
482,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
483,1,Choroidal haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
483,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
484,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
484,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
485,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
486,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
487,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
488,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
489,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
489,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
489,3,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
489,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
490,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
490,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
490,3,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
491,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
491,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
491,3,Uterine enlargement,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
491,4,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
491,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
492,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
492,2,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
492,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
492,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
492,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
492,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
492,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
492,8,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
492,9,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
492,10,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
492,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
492,12,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
492,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
492,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
492,15,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
493,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
494,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
494,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
494,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
494,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
494,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
494,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
495,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
495,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
496,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
496,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
496,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
496,4,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
496,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
497,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
497,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
497,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
498,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
498,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
499,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
499,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
499,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
499,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
499,5,Vaccination site discharge,Vaccination site reactions,Administration site reactions,Genrl,N
500,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
500,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
500,3,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
501,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
502,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
502,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
502,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
503,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
503,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
504,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
505,1,Basal ganglia haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
505,2,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
506,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
507,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
507,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
507,3,Right ventricular failure,Right ventricular failures,Heart failures,Card,Y
508,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
509,1,Lower gastrointestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
510,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
511,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
512,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
512,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
512,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
513,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
514,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
514,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
515,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
515,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
515,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
516,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
516,2,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
516,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
516,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
516,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
517,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
517,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
517,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
517,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
517,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
518,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
519,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
520,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
520,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
520,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
520,4,Incorrect dosage administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
520,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
521,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
522,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
523,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
523,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
523,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
523,4,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
523,5,Mesenteric haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
524,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
524,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
525,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
526,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
527,1,Prosthetic cardiac valve thrombosis,Cardiac complications associated with device,Complications associated with device,Genrl,N
528,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
529,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
529,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
529,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
530,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
530,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
531,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
532,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
533,1,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
534,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
534,2,Headache,Headaches NEC,Headaches,Nerv,N
534,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
535,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
535,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
536,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
537,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
538,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
539,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
539,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
540,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
540,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
540,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
540,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
540,5,Pulmonary infarction,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
541,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
541,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
542,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
542,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
542,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
543,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
544,1,Medical device site discomfort,Complications associated with device NEC,Complications associated with device,Genrl,N
544,2,Medical device site pain,Complications associated with device NEC,Complications associated with device,Genrl,N
544,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
545,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
545,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
546,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
547,1,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
547,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
547,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
547,4,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
548,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
548,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
548,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
548,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
548,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
549,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
550,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
551,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
551,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
551,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
552,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
553,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
554,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
555,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
556,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
557,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
557,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
558,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
559,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
560,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
561,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
562,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
563,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
564,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
564,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
564,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
564,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
565,1,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
566,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
567,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
567,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
567,3,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
567,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
567,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
568,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
568,2,Coronary artery embolism,Coronary artery disorders NEC,Coronary artery disorders,Card,N
568,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
569,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
569,2,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
569,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
569,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
569,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
569,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
569,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
569,8,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
570,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
571,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
572,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
572,2,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
572,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
572,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
573,1,Ocular retrobulbar haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
574,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
574,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
574,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
574,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
574,5,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
574,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
574,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
575,1,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
576,1,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
576,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
577,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
577,2,Pulmonary alveolar haemorrhage,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
578,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
579,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
580,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
580,2,Pulmonary alveolar haemorrhage,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
581,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
582,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
583,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
583,2,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
583,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
584,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
585,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
585,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
585,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
586,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
587,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
587,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
587,3,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
588,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
588,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
589,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
589,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
590,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
591,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
